ShareCast News for Genus (GNS)
A round-up of the biggest director deals today so far.
[23 May '13]Retailer Next is facing a "new normal," something which its Chief Executive, Lord Wolfson of Aspley Guise, describes as an environment where the shopper is careful with his or her money and retailers can no longer expect an automatic year-on-year rise in like-for-like sales. So much so in fact that analysts believe that a sales rise across the group of 2.2 per cent in the 14 weeks to last weekend masks an underlying fall of about 4.4 per cent. Nevertheless, the company contin
[9 May '13]Animal genetics company Genus said results for the first nine months are in line with last year's record performance.
[30 Apr '13]Aviva: Bank of America cuts target price from 350p to 335p, while its neutral rating remains unchanged.
[4 Apr '13]Abcam: Canaccord Genuity moves target price from 344p to 358p, but still recommends selling.
[20 Mar '13]Global animal genetics company Genus posted a minimal rise in half year revenue, but a slight decline in pre-tax profit after an increase in research and development costs for the six months ended December 31st.
[25 Feb '13]Genus announced Thursday that Group Finance Director John Worby will be stepping down after eight years at the leading global animal genetics firm.
[13 Dec '12]Animal genetics group Genus was off slightly on Thursday after it said higher feed costs and the impact of bad weather had dented profits.
[8 Nov '12]